Key antibiotics fail against common hospital bacteria
A WHO and ECDC analysis finds very high resistance levels in nearly half of reporting countries in the European region.

Two common hospital bacteria are resisting important antibiotics at high rates across much of the WHO European Region, according to a new joint analysis from WHO Europe and the European Centre for Disease Prevention and Control.
For Klebsiella pneumoniae, 21 of 43 countries reporting 2025 data found that at least half of tested samples from serious infections were resistant to third-generation cephalosporins. The bacterium can cause dangerous bloodstream infections in hospital patients.
When those medicines are unlikely to work, clinicians may turn to broad-spectrum carbapenems. Resistance to carbapenems is also a concern, particularly for Acinetobacter infections, leaving a smaller group of reserve medicines for difficult cases.
The analysis measures laboratory resistance rather than individual treatment outcomes. Rates vary substantially by country, and the agencies say stronger infection prevention, laboratory capacity, surveillance and careful antibiotic use are all needed.
One regional target has been reached: estimated methicillin-resistant Staphylococcus aureus infections fell 19 per cent between 2019 and 2025. However, rates have risen during the past two years, putting continued progress at risk.
Source
News brief based on the linked WHO Europe and ECDC analysis.